Food and Drug Administration
Pediatric Subcommittee of the Oncologic Drugs Advisory Committee
December 06, 2006
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. §552).
These redacted portions will appear as white space on the screen or on the printed page.
FDA Briefing Document
December 1, 2006